The EASL International Liver Foundation: A growing pup with missions that are distinct yet integrated with those of its mother  Massimo Colombo, Tom Hemming.

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 61, Issue 2, Pages (August 2014)
Volume 63, Issue 1, Pages (July 2015)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Volume 65, Issue 1, Pages S82-S94 (October 2016)
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 68, Issue 5, Pages (May 2018)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Volume 65, Issue 1, Pages S82-S94 (October 2016)
Immigration and viral hepatitis
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Hepatitis B and C virus-related carcinogenesis
Volume 69, Issue 1, Pages (July 2018)
Living donor liver transplantation: is the hype over?
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Volume 69, Issue 2, Pages (August 2018)
The place of downstaging for hepatocellular carcinoma
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Volume 68, Issue 1, Pages (January 2018)
Hepatitis C core protein – The “core” of immune deception?
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Association of non-alcoholic fatty liver disease with renal stone disease detected on computed tomography  In Chul Nam, MD, Jung Hee Yoon, MD, Seung Ha.
Volume 70, Issue 1, Pages (January 2019)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 54, Issue 5, Pages (May 2011)
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Autophagy in the liver Journal of Hepatology
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Age and liver transplantation
Volume 50, Issue 4, Pages (April 2009)
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Chetana Lim, Chady Salloum, Daniel Azoulay
Immigration and viral hepatitis
Evolution of liver transplantation for hepatocellular carcinoma
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
Volume 64, Issue 6, Pages (June 2016)
Volume 63, Issue 1, Pages (July 2015)
Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences  Zobair M. Younossi, Aybike Birerdinc,
Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence  Christian Toso, Gilles Mentha, Pietro.
Statins: Old drugs as new therapy for liver diseases?
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Volume 54, Issue 6, Pages (June 2011)
This Month in AJKD American Journal of Kidney Diseases
Volume 58, Issue 2, Pages (February 2013)
The metabolomic window into hepatobiliary disease
Genetics of hepatocellular carcinoma: The next generation
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Outcomes in liver transplantation: Does sex matter?
Reversion of disease manifestations after HCV eradication
The dawn of a new EASL – A new chapter in the history of the European Association for the Study of the liver  Tom H. Karlsen, Phil N. Newsome  Journal.
Presentation transcript:

The EASL International Liver Foundation: A growing pup with missions that are distinct yet integrated with those of its mother  Massimo Colombo, Tom Hemming Karlsen  Journal of Hepatology  Volume 70, Issue 3, Pages 339-342 (March 2019) DOI: 10.1016/j.jhep.2018.11.017 Copyright © 2018 Terms and Conditions

Fig. 1 The strategic differentiation between EASL and EILF. EASL, the European Association for the Study of the Liver; EILF, the EASL International Liver Foundation. Journal of Hepatology 2019 70, 339-342DOI: (10.1016/j.jhep.2018.11.017) Copyright © 2018 Terms and Conditions

Fig. 2 The viral hepatitis micro-elimination network orchestrated by the EILF. EAHAD, The European Association for Haemophilia and Allied Disorders; EHC, European Haemophilia Consortium; EILF, the European Association for the Study of the Liver International Liver Foundation; ERA-EDTA, European Renal Association – European Dialysis and Transplant Association; SerT, Servizi Tossicodipendenze; SIMIT, Società Italiana di Malattie Infettive e Tropicali; TIF, Thalassaemia International Federation; UNRWA, United Nations Relief and Works Agency for Palestine Refugees in the Near East. Journal of Hepatology 2019 70, 339-342DOI: (10.1016/j.jhep.2018.11.017) Copyright © 2018 Terms and Conditions

Fig. 3 EILF key initiatives. CKD, chronic kidney disease; EILF, the European Association for the Study of the Liver International Liver Foundation; GOLD, guidance on liver disease; HCC, hepatocellular carcinoma; NAFLD, non-alcoholic fatty liver diseases; PWIDs, people who inject drugs; VHE, viral hepatitis elimination. Journal of Hepatology 2019 70, 339-342DOI: (10.1016/j.jhep.2018.11.017) Copyright © 2018 Terms and Conditions